Shares of Arvinas, Inc. (ARVN) have traded between $14.07 – 52.94. The next earnings date is set for Mar 24, 2020. Let’s see how its prospects are shaping up.

What does Arvinas, Inc.(ARVN) do?

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT.

ARVN Insider Trading Insight

On 2019-11-19, Cassidy Sean A CFO sold 10,000 shares of ARVN. That represents a value of $159,115. Not to be outdone, on 2019-11-13, Taylor Ian S – Sale sold10,000 shares of ARVN. These insiders are clearly in the know because they work closely with the company.

The SPT Consensus Price Target

The mean recommendation of Sprout Social, Inc. from top Wall Street analysts is a Strong Buy. That is based on 5 analysts who work on the Street. Based on 5 analysts offering 12 month price targets for Sprout Social in the last 3 months. The average price target is $24.25 with a high forecast of $27.00 and a low forecast of $22.00. The average price target represents a 21.25% increase from the last price of $20.00. Last week, several articles were published in financial papers about SPT and 33% Bearish while 67% Bullish.